Prognostic relevance of a novel proliferation marker, Ki-S11, for soft- tissue sarcoma: A multivariate study

American Journal of Pathology

Volumn 150, Issue 6, 1997, Pages 1997-2007

  Rudolph, Pierre ^a   Kellner, Udo ^a   Chassevent, Agnès ^b   Colling, Françoise ^b   Bonichon, Françoise ^b   Parwaresch, Reza ^a   Coindre, Jean Michel ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b French Federation of Cancer Centers   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); MONOCLONAL ANTIBODY KI 67; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MITOSIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE SARCOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; BLOTTING, WESTERN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; S PHASE; SARCOMA; SURVIVAL ANALYSIS;

EID: 0031009938     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Ueda T, Aozasa K, Tsujimoto M, Hamada H, Hayashi H, Ono K, Matsumoto K: Multivariate analysis for clinical prognostic factors in 163 patients with soft tissue sarcoma. Cancer 1988, 62:1444-1450
2. Kraus DH, Dubner S, Harrison LB, Strong EW, Hajdu SI, Kher U, Begg C, Brennan MF: Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas. Cancer 1994, 74:697-702
3. Tanabe KK, Pollock RE, Ellis LM, Murphy A, Sherman N, Romsdahl MM: Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas. Cancer 1994, 73:1652-1659
4. Mandard AM, Petiot JF, Marnay J, Mandard JC, Chasle J, de Ranieri E, Dupin P, Herlin P, de Ranieri J, Tanguy A, Boulier N, Abbatucei JS: Prognostic factors in soft tissue sarcomas: a multivariate analysis of 109 cases. Cancer 1989, 63:1437-1451
5. Gaynor JJ, Tan CC, Casper ES, Collin CF, Friedrich C, Shiu M, Hajdu SI, Brennan MF: Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults. J Clin Oncol 1992, 10:1317-1329
6. Costa J, Wesley RA, Glatstein E, Rosenberg SA: The grading of soft tissue sarcomas: results of a clinicohistopathologic correlation in a series of 163 cases. Cancer 1984, 53:530-541
7. Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, Goussot JF, David M, Bonichon F, Lagarde C: Soft-tissue sarcomas of adults: study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984, 33:37-42
8. Coindre JM, Terrier P, Bui NB, Bonichon F, Collin F, Le Doussal V, Mandard AM, Vilain MO, Jacquemier J, Duplay H, Sastre X, Barlier C, Henry-Amar M, Macé-Lesech J, Contesso G: Prognostic factors in adult patients with locally controlled soft tissue sarcoma: a study on 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996, 14:869-877
9. Guillou L, Coindre JM, Bonichon F, Bui NB, Terrier P, Collin F, Vilain MO, Mandard AM, Le Doussal V, Leroux A, Jacquemier J, Duplay H, Sastre X, Costa J: A comparative study of the NCI and FNCLCC grading systems in a population of 410 adult patients with a soft tissue sarcoma. J Clin Oncol 1997, 15:350-362
10. Broders AC, Hargrave R, Meyerding HW: Pathologic features of soft tissue fibrosarcoma with special reference to the grading of its malignancy. Surg Gynecol Obstet 1939, 69:267-280
11. Russell WO, Cohen J, Enzinger F, Hajdu SI, Heise H, Martin RG, Meissner W, Miller WT, Schmitz RL Suit HD: A clinical and pathological staging system for soft tissue sarcomas, Cancer 1977, 40:1562-1570
12. Markhede G, Angervall L, Stener B: A multivariate analysis of the prognosis after surgical treatment of malignant soft tissue tumors. Cancer 1982, 49:1721-1733
13. Myhre-Jensen O, Hogh J, Ostgaard SE, Nordentoft AM, Sneppen O: Histopathological grading of soft tissue tumors: prognostic significance in a prospective study of 278 consecutive cases, J Pathol 1991, 163:19-24
14. Van Unnik JAM, Coindre JM, Contesso G, Albus-Lutter CE, Schiodt T, Sylvester R, Thomas D, Bramwell V, Mouridsen HT: Grading of soft tissue sarcomas: experience of the EORTC soft tissue and bone sarcoma group. Eur J Cancer 1993, 29A:2089-2093
15. Tomita Y, Aozasa K, Myoui A, Kuratsu S, Uchida A, Ono K, Matsumoto K: Histologic grading in soft-tissue sarcomas. An analysis of 194 cases including AgNor count and mast-cell count. Int J Cancer 1993, 54:194-199
16. Weiss SW: Histological typing of soft tissue tumours. World Health Organization: International Histological Classification of Tumours, ed 2. Berlin, Springer Verlag, 1994
17. Coindre JM, Trojani M, Contesso G, David M, Rouesse J, Bui NB, Bodaert A, de Mascarel I, de Mascarel A, Goussot JF: Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986, 58:306-309
18. Donhuijsen K: Mitosis counts: reproducibility and significance in grading of malignancy. Hum Pathol 1986, 17:1122-1125
19. Donhuijsen K, Schmidt U, Hirche H, van Beuningen D, Budach V: Changes in mitotic rate and cell cycle fractions caused by delayed fixation. Hum Pathol 1990, 21:709-714
20. Ueda T, Aozasa K, Tsujimoto M, Ohsawa M, Uchida A, Aoki Y, Quo K, Matsamoto K: Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer 1989, 63:1607-1611
21. Rudolph P, Lappe T, Schubert C, Schmidt D, Parwaresch RM, Christophers E: Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions. Am J Pathol 1995, 147:1615-1625
22. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984, 133:1710-1715
23. Gerdes J, Li L, Schlüter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad H-D: Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991, 138:867-873
24. Camplejohn RS, Brock A, Barnes DM, Gillett C, Raikundalia B, Kreipe H, Parwaresch MR: Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells. Br J Cancer 1993, 67:657-662
25. Kreipe H, Alm P, Olsson H, Hauberg M, Fischer L, Parwaresch R: Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1. Am J Pathol 1993, 142:651-657
26. Sampson SA, Kreipe H, Gillett CE, Smith P, Chaudary MA, Khan A, Wicks K, Parwaresch R, Barnes DM: KiS1-a novel monoclonal antibody which recognizes proliferating cells: evaluation of its relationship to prognosis in mammary carcinoma. J Pathol 1992, 168:179-185
27. Enzinger FM, Weiss SW: Soft Tissue Tumors, ed 3. St. Louis, MO, Mosby, 1995
28. Kellner U, Heidebrecht HJ, Rudolph P, Biersack H, Buck F, Dakowski T, Wacker HH, Domanowski M, Seidel A, Westergaard O, Parwaresch R: Detection of topoisomerase II α in cell lines and tissues: characterization of five novel monoclonal antibodies. J Histochem Cytochem 1997, 45:1-13
29. Collin F, Chassevent A, Bonichon F, Bertrand G, Terrier P, Coindre JM: Flow cytometric desoxyribonucleic acid content analysis in 185 soft tissue tumors with reference to tumor heteroqeueity, Cancer 1997 (in press)
30. Rudolph P, Lappe T, Hero B, Berthold F, Parwaresch R, Harms D, Schmidt D: Prognostic significance of the proliferative activity in neuroblastoma. Am J Pathol 1997, 150:133-145
31. Papadopoulos I, Rudolph P, Weichert-Jacobsen K: Value of p53 expression, cellular proliferation and DNA content as prognostic indicators in renal cell carcinoma. Eur Urol 1996
32. Hashimoto H, Daimaru Y, Takeshita S, Tsuneyoshi M, Enjoji M: Prognostic significance of histologic parameters of soft tissue sarcomas. Cancer 1992, 70:2816-2822
33. Schlüter C, Duchrow M, Wohlenberg C, Becker MHG, Key G, Flad H-D, Gerdes J: The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining protein. J Cell Biol 1993, 123:513-522
34. Leong AS-Y, Vinyuvat S, Suthipintawong C, Milios J: A comparative study of cell proliferation markers in breast carcinomas. Clin Mol Pathol 1995, 48:M83-M87
35. Lopez F, Belloc F, Lacombe F, Dumain P, Feiffers J, Bernard P, Boisseau MR: The labeling of proliferating cells by Ki67 and Mib-1 antibodies depends on the binding of a nuclear protein to the DNA. Exp Cell Res 1994, 210:145-153
36. Rudolph P, Heidebrecht H-J, Kellner U, Seidel A, Parwaresch MR: Proliferation marker Ki-S1 binds to a formalin-resistant epitope of topoisomerase II. Int J Surg Pathol 1995, 2:388
37. Liu LF: DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 1989, 58:321-375
38. el Jabbour JN, Akhtar SS, Kerr GR, McLaren KM, Smyth JF, Rodger A, Leonard RC: Prognostic factors for survival in soft tissue sarcoma. Br J Cancer 1990, 62:857-861
39. Singer S, Corson JM, Gonin R, Labow B, Eberlein TJ: Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma. Ann Surg 1994, 219:165-173
40. Baak JPA: Mitosis counting in tumors. Hum Pathol 1990, 21:683-685
41. Stenfert Kroese MC, Rutgers DH, Wils IS, Van Unnik JAM, Roholl PJM: The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors. Cancer 1990, 65:1782-1788
42. Choong PF, Akerman M, Willen H, Andersson C, Gustafson P, Baldetorp B, Ferno M, Alvegard T, Rydholm A: Prognostic value of Ki-67 expression in 182 soft tissue sarcomas: proliferation-a marker of metastasis? APMIS 1994, 102:915-924
43. Dreinhofer KE, Akerman M, Willen H, Anderson C, Gustafson P, Rydholm A: Proliferating cell nuclear antigen (PCNA) in high-grade malignant fibrous histiocytoma: prognostic value in 48 patients. Int J Cancer 1994, 59:379-382
44. Drobnjak M, Latres E, Pollack D, Karpeh M, Dudas M, Woodruff JM, Brennan MF, Cordon Cardo C: Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas. J Natl Cancer Inst 1994, 86:549-554
45. Agarwal V, Greenebaum E, Wersto R, Koss LG: DNA ploidy of spindle cell soft-tissue tumors and its relationship to histology and clinical outcome. Arch Pathol Lab Med 1991, 115:558-562
46. el Naggar AK, Ordonez NG, Sara A, McLemore D, Batsakis JG: Clear cell sarcomas and metastatic soft tissue melanomas: a flow cytometric comparison and prognostic implications. Cancer 1991, 67:2173-2179
47. Alvegard TA, Berg NO, Baldetorp B, Ferno M, Killander D, Ranstam J, Rydholm A, Akerman M: Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience. J Clin Oncol 1990, 8:538-547
48. Alho A, Skjeldal S, Melvik JE, Pettersen EO, Larsen TE: The clinical importance of DNA synthesis and aneuploidy in bone and soft tissue tumours. Anticancer Res 1993, 13:2383-2387
49. Tsushima K, Rainwater LM, Goellner JR, van Heerden JA, Lieber MM: Leiomyosarcomas and benign smooth muscle tumors of the stomach: nuclear DNA patterns studied by flow cytometry. Mayo Clin Proc 1987, 62:275-280
50. Bauer HC, Kreicbergs A, Tribukait B: DNA content prognostic in soft tissue sarcoma: 102 patients followed for 1-10 years. Acta Orthop Scand 1991, 62:187-194
51. Gustafson P, Willen H, Baldetorp B, Ferno M, Akerman M, Rydholm A: Soft tissue leiomyosarcoma: a population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content. Cancer 1992, 70:114-119
52. Gustafson P, Rydholm A, Willen H, Baldetorp B, Ferno M, Akerman M: Liposarcoma: a population-based epidemiologic and prognostic study of features of 43 patients, including tumor DNA content. Int J Cancer 1993, 55:541-546
53. Huuhtanen RL, Blomqvist CP, Wiklund TA, Virolainen MJ, Inkeri Elomaa A, Pan Y, Tribukait B: S-phase fraction of 155 soft tissue sarcomas: correlation with clinical outcome. Cancer 1996, 77:1815-1822
54. Becker RLJ, Venzon D, Lack EE, Mikel UV, Weiss SW, O'Leary TJ: Cytometry and morphometry of malignant fibrous histiocytoma of the extremities: prediction of metastasis and mortality. Am J Surg Pathol 1991, 15:957-964